PODD
Insulet
Earnings and EPS analysis
- Stocks
- Healthcare
- NASDAQ: PODD
- Earnings
EPS in 2026 (TTM): $4.3
Last Report Period Date: Mar 31, 2026
Currently, PODD's 12-month EPS stands at $4.3, according to the most recent financial reports. During 2025, PODD reported a per-share earnings of $3.51, which shows a decline compared to the EPS of $5.97 recorded in 2024. PODD recorded an EPS of $1.3 for the quarterly period ending on Mar 31, 2026.
PODD earnings history
In 2025, Insulet's earnings per share was $3.51, a decline of 41.2% from $5.97 in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $1.3, reflecting a 160% increase compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $4.3. During 2024, the annual earnings per share was $5.97, representing an increase of 101.7% compared to 2023.
PODD earnings chart
PODD EPS growth history
In the past 12 months, Insulet has recorded an earnings per share growth rate of 160% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 268.8% per year. In the last five years, the company had an average annual EPS growth of 99.9%.
PODD Earnings Waterfall
PODD Earnings vs Peers
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| MDT Medtronic plc | 21.5 | 3.3% | 9.8% | 6.9% |
| ABT Abbott Laboratories | 25.19 | -51.4% | -1.8% | 8.2% |
| JNJ Johnson & Johnson | 27.39 | 90.6% | 17.7% | 14.8% |
| DXCM Dexcom Inc | 28.7 | 46.6% | 34.5% | 7.9% |
| PODD Insulet Corp | 33.48 | -41.2% | 268.8% | 99.9% |
| LLY ELI LILLY & Co | 39.19 | 95.6% | 49.2% | 27.5% |
| ICUI Icu Medical Inc | 72.45 | 100.6% | N/A | -62.7% |
| DCTH Delcath Systems Inc | 614 | 108.6% | N/A | N/A |
| TNDM Tandem Diabetes Care Inc | N/A | -106.8% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.